SEC Form 4 · accession 0001209191-16-139191
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred Broadway
Officer — SVP - Sales Marketing
Period of report
Aug 26, 2016
Accepted (ET)
Aug 30, 2016 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 26, 2016 | S | 4,772 | $19.20 | D | 71,719 | D | |
| Common StockF3 | Aug 29, 2016 | S | 5,105 | $18.95 | D | 66,614 | D | |
| Common StockF4 | Aug 30, 2016 | S | 2,244 | $19.07 | D | 64,370 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2016
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.85 to $19.42, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- F3This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.76 to $19.28, inclusive.
- F4This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.88 to $19.30, inclusive.